RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Susan Yeyeodu to Humans

This is a "connection" page, showing publications Susan Yeyeodu has written about Humans.
Connection Strength

0.076
  1. Yeyeodu ST, Kidd LR, Kimbro KS. Protective Innate Immune Variants in Racial/Ethnic Disparities of Breast and Prostate Cancer. Cancer Immunol Res. 2019 09; 7(9):1384-1389.
    View in: PubMed
    Score: 0.035
  2. Martin ME, Reaves DK, Jeffcoat B, Enders JR, Costantini LM, Yeyeodu ST, Botta D, Kavanagh TJ, Fleming JM. Silver nanoparticles alter epithelial basement membrane integrity, cell adhesion molecule expression, and TGF-?1 secretion. Nanomedicine. 2019 10; 21:102070.
    View in: PubMed
    Score: 0.009
  3. Fleming JM, Yeyeodu ST, McLaughlin A, Schuman D, Taylor DK. In Situ Drug Delivery to Breast Cancer-Associated Extracellular Matrix. ACS Chem Biol. 2018 10 19; 13(10):2825-2840.
    View in: PubMed
    Score: 0.008
  4. Spruiell K, Gyamfi AA, Yeyeodu ST, Richardson RM, Gonzalez FJ, Gyamfi MA. Pregnane X Receptor-Humanized Mice Recapitulate Gender Differences in Ethanol Metabolism but Not Hepatotoxicity. J Pharmacol Exp Ther. 2015 Sep; 354(3):459-70.
    View in: PubMed
    Score: 0.006
  5. Rogers EN, Jones DZ, Kidd NC, Yeyeodu S, Brock G, Ragin C, Jackson M, McFarlane-Anderson N, Tulloch-Reid M, Sean Kimbro K, Kidd LR. Toll-like receptor-associated sequence variants and prostate cancer risk among men of African descent. Genes Immun. 2013 Sep; 14(6):347-55.
    View in: PubMed
    Score: 0.006
  6. Lavender NA, Rogers EN, Yeyeodu S, Rudd J, Hu T, Zhang J, Brock GN, Kimbro KS, Moore JH, Hein DW, Kidd LC. Interaction among apoptosis-associated sequence variants and joint effects on aggressive prostate cancer. BMC Med Genomics. 2012 Apr 30; 5:11.
    View in: PubMed
    Score: 0.005
  7. Collette J, Bocock JP, Ahn K, Chapman RL, Godbold G, Yeyeodu S, Erickson AH. Biosynthesis and alternate targeting of the lysosomal cysteine protease cathepsin L. Int Rev Cytol. 2004; 241:1-51.
    View in: PubMed
    Score: 0.003
  8. Weaver KD, Yeyeodu S, Cusack JC, Baldwin AS, Ewend MG. Potentiation of chemotherapeutic agents following antagonism of nuclear factor kappa B in human gliomas. J Neurooncol. 2003 Feb; 61(3):187-96.
    View in: PubMed
    Score: 0.003
  9. Godbold GD, Ahn K, Yeyeodu S, Lee LF, Ting JP, Erickson AH. Biosynthesis and intracellular targeting of the lysosomal aspartic proteinase cathepsin D. Adv Exp Med Biol. 1998; 436:153-62.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support